Correspondence 0001387131-23-010567 from PULSE BIOSCIENCES, INC. (PLSE)
PULSE BIOSCIENCES, INC.
Date: Aug. 29, 2023 · CIK: 0001625101 · Accession: 0001387131-23-010567
AI Filing Summary & Sentiment
Reasoning
File numbers found in text: 333-273944
Letter
PULSE BIOSCIENCES, INC.
3957 Point Eden Way
Hayward, CA 94545
(510) 906-4600
August 29, 2023
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re: Pulse Biosciences, Inc. Registration Statement on Form S-3
File No. 333-273944
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under the Securities Act of 1933, as amended, Pulse Biosciences, Inc. (the “Registrant”) hereby requests acceleration of the effective date of its Registration Statement on Form S-3 (File No. 333-273944) (the “Registration Statement”), so that it may become effective at 4:00 p.m. Eastern time on August 30, 2023 or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(a) should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(b) the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(c)
the Registrant may not assert staff comments and the declaration of effectiveness of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws of the United States.
We request that we be notified of such effectiveness by a telephone call to Adam Finerman, of Baker & Hostetler LLP, at (212) 589-4233 or by email at afinerman@bakerlaw.com.
[Remainder of this page is intentionally left blank]
Very truly yours,
PULSE BIOSCIENCES, INC.
Show Raw Text
CORRESP
1
filename1.htm
PULSE BIOSCIENCES, INC.
3957 Point Eden Way
Hayward, CA 94545
(510) 906-4600
August 29, 2023
Via EDGAR
Securities and Exchange Commission
Division of Corporation Finance
100 F Street, N.E.
Washington, D.C. 20549
Re:
Pulse Biosciences, Inc.
Registration Statement on Form S-3
File No. 333-273944
Request for Acceleration
Ladies and Gentlemen:
Pursuant to Rule 461 promulgated under
the Securities Act of 1933, as amended, Pulse Biosciences, Inc. (the “Registrant”) hereby requests acceleration of
the effective date of its Registration Statement on Form S-3 (File No. 333-273944) (the “Registration Statement”),
so that it may become effective at 4:00 p.m. Eastern time on August 30, 2023 or as soon thereafter as practicable.
The Registrant hereby acknowledges that:
(a)
should the Securities and Exchange Commission (the “Commission”) or the staff, acting pursuant to delegated authority, declare the Registration Statement effective, it does not foreclose the Commission from taking any action with respect to the Registration Statement;
(b)
the action of the Commission or the staff, acting pursuant to delegated authority, in declaring the Registration Statement effective, does not relieve the Registrant from its full responsibility for the adequacy and accuracy of the disclosure in the Registration Statement; and
(c)
the Registrant may not assert staff comments and the declaration of effectiveness
of the Registration Statement as a defense in any proceeding initiated by the Commission or any person under the federal securities laws
of the United States.
We request that we be notified of such effectiveness by a telephone call
to Adam Finerman, of Baker & Hostetler LLP, at (212) 589-4233 or by email at afinerman@bakerlaw.com.
[Remainder of this page is intentionally left blank]
Very truly yours,
PULSE BIOSCIENCES, INC.
By:
/s/ Kenneth B. Stratton
Name:
Kenneth B. Stratton
Title:
General Counsel
[Signature Page
to Request for Acceleration]